Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2012

Feb 16, 2012

30016_dirs_2012-02-16_52a43853-72aa-41ce-bab2-6f671b432809.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-02-14

Reporting Person: AYERS JONATHAN W (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-14 Common Stock M 1200 Acquired 328991 Direct
2012-02-14 Common Stock M 1600 Acquired 330591 Direct
2012-02-14 Common Stock M 1600 Acquired 332191 Direct
2012-02-14 Common Stock M 1200 Acquired 333391 Direct
2012-02-14 Common Stock M 1200 Acquired 334591 Direct
2012-02-14 Common Stock F 3055 $87.42 Disposed 331536 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-14 Non-Qualified Stock Option (right to buy) $87.42 A 58857 Acquired 2019-02-13 Common Stock (58857) Direct
2012-02-14 Incentive Stock Option (right to buy) $87.42 A 1143 Acquired 2019-02-13 Common Stock (1143) Direct
2012-02-14 Restricted Stock Unit $ A 6000 Acquired Common Stock (6000) Direct
2012-02-14 Restricted Stock Unit $ M 1200 Disposed Common Stock (1200) Direct
2012-02-14 Restricted Stock Unit $ M 1600 Disposed Common Stock (1600) Direct
2012-02-14 Restricted Stock Unit $ M 1600 Disposed Common Stock (1600) Direct
2012-02-14 Restricted Stock Unit $ M 1200 Disposed Common Stock (1200) Direct
2012-02-14 Restricted Stock Unit $ M 1200 Disposed Common Stock (1200) Direct

Footnotes

F1: Grant of options to buy shares of common stock becomes exercisable as to 12,000 shares on 02/14/2013, 02/14/2014, 02/14/2015 and 02/14/2016, and the remaining 10,857 shares on 02/14/2017.

F2: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2017) of the grant.

F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.

F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.

F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.

F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.

F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.

F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2008) of the date of grant.